Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Sep. 30, 2018 | Nov. 13, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | BIONOVATE TECHNOLOGIES CORP. | |
Entity Central Index Key | 1,575,420 | |
Trading Symbol | biio | |
Document Period End Date | Sep. 30, 2018 | |
Current Fiscal Year End Date | --06-30 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Is Entity's Reporting Status Current? | Yes | |
Entity Emerging Growth Company | true | |
Entity Small Business | true | |
Entity Ex Transition Period | false | |
Entity Common Stock, Shares Outstanding | 15,579,749 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2,019 | |
Entity Filer Category | Non-accelerated Filer |
CONDENSED INTERIM BALANCE SHEET
CONDENSED INTERIM BALANCE SHEETS - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Current Assets | ||
Cash | ||
Total Current Assets | ||
TOTAL ASSETS | ||
Current Liabilities | ||
Accounts payable and accrued liabilities | 67,687 | 40,506 |
Due to related parties | 41,025 | 186,281 |
Convertible notes payable | 142,956 | 82,895 |
Total Current Liabilities | 251,668 | 309,682 |
TOTAL LIABILITIES | 251,668 | 309,682 |
Stockholders' Deficit | ||
Preferred stock: 90,000,000 authorized; $0.0001 par value - no shares issued and outstanding | ||
Common stock: 100,000,000 authorized; $0.0001 par value 15,579,749 shares issued and outstanding | 1,558 | 1,558 |
Additional paid in capital | 2,201,582 | 2,056,059 |
Accumulated deficit | (2,454,808) | (2,367,299) |
Total Deficit | (251,668) | (309,682) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
CONDENSED INTERIM BALANCE SHE_2
CONDENSED INTERIM BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2018 | Jun. 30, 2018 |
Stockholders' Deficit | ||
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares issued | 15,579,749 | 15,579,749 |
Common stock, shares outstanding | 15,579,749 | 15,579,749 |
Preferred stock, shares authorized | 90,000,000 | 90,000,000 |
Preferred stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
CONDENSED INTERIM STATEMENT OF
CONDENSED INTERIM STATEMENT OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Condensed Interim Statement Of Operations | ||
Revenues | ||
Cost of goods sold | ||
Gross profit | ||
Operating Expenses | ||
General and administration | 4,930 | 33,412 |
Professional | 10,171 | 1,230 |
Total operating expenses | 15,101 | 34,642 |
Net loss from operations | (15,101) | (34,642) |
Other income (expense) | ||
Foreign currency gain | (374) | 6,197 |
Interest expense | (72,034) | (5,335) |
Total other income (expense) | (72,408) | 862 |
Net loss before taxes | (87,509) | (33,780) |
Net loss | (87,509) | (33,780) |
Comprehensive loss | (87,509) | (33,780) |
Foreign currency adjustment | (14,013) | |
Comprehensive Loss | $ (87,509) | $ (47,793) |
Basic and dilutive loss per share | ||
Net loss | $ (0.01) | $ (0.11) |
Weighted average number of shares outstanding | 15,579,749 | 299,400 |
CONDENSED INTERIM STATEMENT O_2
CONDENSED INTERIM STATEMENT OF CASH FLOWS (Unaudited( - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (87,509) | $ (33,780) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Amortization of debt discount | 60,000 | 2,060 |
Foreign currency adjustment | 328 | (6,197) |
Changes in operating assets and liabilities: | ||
Accounts payable and accrued liabilities | 27,181 | 5,417 |
Accrued salary | 32,500 | |
Net cash provided by operating activities | ||
Net change in cash and cash equivalents | ||
Cash and cash equivalents, beginning of period | ||
Cash and cash equivalents, end of period | ||
Supplemental cash flow information | ||
Cash paid for interest | ||
Cash paid for taxes | ||
Non-cash transactions: | ||
Convertible note exchanged for due to related parties | 60,000 | |
Beneficial conversion feature | 60,000 | |
Debt forgiveness | 85,523 | |
Accounts payable paid by related party | $ 15,532 |
NATURE AND CONTINUANCE OF OPERA
NATURE AND CONTINUANCE OF OPERATIONS | 3 Months Ended |
Sep. 30, 2018 | |
Notes to Financial Statements | |
NOTE 1 - NATURE AND CONTINUANCE OF OPERATIONS | Bionovate Technologies Corp. (the “Company”, or the “Corporation”) was incorporated in the state of Nevada, United States on October 24, 2012 under the name MJP International Ltd. On December 1, 2017, the Company’s corporate name was changed to Bionocate Technologies Corp. The Corporation was formed and organized to capitalize on new opportunities found in the North American market for light-emitting diode (“LED”) lighting. With China as the manufacturing backbone of future LED products, the Corporation has set up an office in Guangzhou, China in search of high quality products offered by reputable manufacturers to be introduced to Canada, the United States, and abroad. The Corporation has set out further details of the acquisition below as well as in Notes 3 and 4 to these consolidated financial statements. On February 5, 2016, Energy Alliance Labs Inc. (“Energy Alliance”), incorporated on February 5, 2016, entered into an agreement to acquire 80% of the issued and outstanding equity interests of Human Energy Alliance Laboratories Corp., an Idaho corporation (“HEAL”) from certain shareholders of HEAL for $80,000. The cash for the acquisition of shares was transferred to the shareholders on November 1, 2016 and that is when the acquisition closed. Subsequent to the transfer of cash, the previous shareholders of the Company owned 80% of the issued and outstanding shares of HEAL. On October 28, 2016, the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Liao Zu Guo, an individual residing in China, whereby the Company issued 80,000 shares of its common stock in exchange for 100% of the issued and outstanding equity interests of Energy Alliance. Subsequent to the execution of the Share Exchange Agreement, Liao Zu Gao became a member of the Board of Directors of the Company. On January 1, 2017, the Company entered into transfer agreement with Liao Zu Guo, whereby the Company transferred 100% of issued and outstanding equity interests of Energy Alliance for $20,000 for past services provided by Executive to the Company and agreed to assume the debt of Energy Alliance owed to the Liao Zu Guo in the aggregate amount of $28,239. On December 1, 2017, a majority of stockholders and the board of directors approved a reverse stock split of the issued and outstanding shares of common stock on a fifty (50) old for one (1) new basis. A Certificate of Amendment was filed with the Nevada Secretary of State on December 11, 2017 with an effective date of December 21, 2017. All share and per share information in these financial statements retroactively reflect this stock distribution. Our executive offices are located at 3006 E. Goldstone Drive, Suite 218, Meridian, ID 83642. Our telephone number is (208) 231 – 1606. Going Concern These condensed interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Corporation and its subsidiaries will be able to meet its obligations and continue its operations for the next fiscal year. Realizable values may be substantially different from carrying values as shown and these condensed interim financial statements, which do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Corporation be unable to continue as a going concern. At September 30, 2018, the Corporation had not yet achieved profitable operations and has an accumulated loss of $2,454,808 since inception. The Corporation expects to incur further losses, all of which casts substantial doubt about the Corporation’s ability to continue as a going concern. The Corporation’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management anticipates that additional funding will be in the form of equity financing from the sale of common stock. Management may also seek to obtain short-term loans from the directors of the Corporation. There are no current arrangements in place for equity funding or short-term loans. |
BASIS OF PRESENTATION
BASIS OF PRESENTATION | 3 Months Ended |
Sep. 30, 2018 | |
Basis Of Presentation | |
NOTE 2 - BASIS OF PRESENTATION | The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended September 30, 2018, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2018. For further information, refer to the financial statements and footnotes thereto included in the Corporation’s filed Form 10-K for the year ended June 30, 2018. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect application of policies and the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying unaudited condensed interim financial statements include the provision for unpaid loss and loss adjustment expenses which may result from product warranty provisions; valuation of deferred income taxes; valuation and impairment assessment of intangible assets; goodwill recoverability; and deferred acquisition costs. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Sep. 30, 2018 | |
Notes to Financial Statements | |
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Revenue Recognition Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. We currently do not have operations, and its management seeks to acquire cash generating businesses. Fair Value of Financial Instrument The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments. Basic and Diluted Loss per Common Stock FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. |
CONVERTIBLE NOTE
CONVERTIBLE NOTE | 3 Months Ended |
Sep. 30, 2018 | |
Notes to Financial Statements | |
NOTE 4 - CONVERTIBLE NOTE | Convertible notes payable at September 30, 2018 and June 30, 2018, consists of the following: September 30, June 30, 2018 2018 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 10,489 10,489 Dated January 1, 2017 - 2 6,200 6,200 Dated January 1, 2017 - 3 3,483 3,422 Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 - Dated July 5, 2018 - 2 15,000 - Dated July 5, 2018 - 3 15,000 - Total convertible notes payable 142,956 82,895 Less: Unamortized debt discount - - Total convertible notes 142,956 82,895 Less: current portion of convertible notes 142,956 82,895 For the three months ended September 30, 2018 and 2017, the Company recognized interest expense of $12,034 and $3,275 and amortization of discount, included in interest expense, of $60.000 and $2,060, respectively. As of September 30, 2018, and June 30, 2018, the Company recorded accrued interest of $35,808 and $23,727, respectively Dated November 1, 2016 On November 1, 2016, the Company issued a convertible note with a conversion price of $0.005 to extinguish debt of $18,239. The convertible note is unsecured, bears interest at 4% per annum and due and payable on November 1, 2017. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $18,239. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 1 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $10,000. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $10,000. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 2 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $14,289. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $14,289. During the year ended June 30, 2018, the convertible note of $3,800 was converted into 760,000 shares of common stock. Dated January 1, 2017 - 3 On January 1, 2017, the Company issued a convertible note with a conversion price of $0.005 to extinguish amounts due to related parties of $3,352 (Canadian dollar (“CAD”) $4,500). The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $3,352 (CAD $4,500). The difference of amount was a result of change of exchange rate. Dated June 30, 2017 On June 30, 2017, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $9,969. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $9,969. Dated April 1, 2018 – 1 and 2 On April 1, 2018, the Company issued 2 convertible notes totaling of $20,000 with a conversion price of $0.01 to pay a purchase of a patent of $10,000. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $20,000. Dated June 30, 2018 On June 30, 2018, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $28,376. The convertible note is unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $28,376. Dated July 5, 2018 – 1, 2 and 3 On June 30, 2018, the Company issued 3 convertible notes totaling of $60,000 with a conversion price of $0.01 to extinguish amounts due to related parties of $145,523. The convertible notes are unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $60,000. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $60,000. |
DUE TO RELATED PARTIES
DUE TO RELATED PARTIES | 3 Months Ended |
Sep. 30, 2018 | |
Notes to Financial Statements | |
NOTE 5 - DUE TO RELATED PARTIES | As at September 30, 2018, the Company was obligated to shareholders for funds advanced to the Corporation for working capital. During the three months ended September 30, 2018, the Company’s CEO paid accounts payable of $41,025 on behalf of the Company. The loans are unsecured, non-interest bearing and due on demand. On July 5, 2018, the Company settled due to related parties of $145,523 (CAD 191,000) by issuing convertible notes of $60,000 to the third parties (Note 4). As a result, the Company recorded debt forgiveness of $85,523 as additional paid in capital. As of September 30, 2018, and June 30, 2018, due to related party was $41,025 and $186,281, respectively. |
CAPITAL STOCK
CAPITAL STOCK | 3 Months Ended |
Sep. 30, 2018 | |
Basis Of Presentation | |
NOTE 6 - CAPITAL STOCK | During the three months ended September 30, 2018, there were no issuance of common stock. As at September 30, 2018 and June 30, 2018, 15,579,749 shares of common stock were issued and outstanding. As at September 30, 2018, there were no warrants or options outstanding. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Sep. 30, 2018 | |
Summary Of Significant Accounting Policies | |
Revenue Recognition | Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: · identify the contract with a customer; · identify the performance obligations in the contract; · determine the transaction price; · allocate the transaction price to performance obligations in the contract; and · recognize revenue as the performance obligation is satisfied. We currently do not have operations, and its management seeks to acquire cash generating businesses. |
Fair Value of Financial Instrument | The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments. |
Basic and Diluted Loss per Common Stock | FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. |
CONVERTIBLE NOTE (Tables)
CONVERTIBLE NOTE (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Convertible Note | |
Schedule of convertible note payable | September 30, June 30, 2018 2018 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 10,489 10,489 Dated January 1, 2017 - 2 6,200 6,200 Dated January 1, 2017 - 3 3,483 3,422 Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 - Dated July 5, 2018 - 2 15,000 - Dated July 5, 2018 - 3 15,000 - Total convertible notes payable 142,956 82,895 Less: Unamortized debt discount - - Total convertible notes 142,956 82,895 Less: current portion of convertible notes 142,956 82,895 |
NATURE AND CONTINUANCE OF OPE_2
NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) - USD ($) | Feb. 05, 2016 | Oct. 28, 2016 | Sep. 30, 2018 | Jun. 30, 2018 |
State of incorporation | Nevada | |||
Date of incorporation | Oct. 24, 2012 | |||
Reverse stock split | Fifty (50) old for one (1) new basis | |||
Accumulated deficit | $ (2,454,808) | $ (2,367,299) | ||
Human Energy Alliance Laboratories Corp [Member] | ||||
Issued and outstanding equity interests | 80.00% | |||
January 1, 2017 [Member] | ||||
Assumption of due to related party | (28,239) | |||
Consideration for past services provided by Executive to the company | $ 20,000 | |||
Liao Zu Guo [Member] | Human Energy Alliance Laboratories Corp [Member] | ||||
Cash for acquisition of shares | $ 80,000 | |||
Liao Zu Guo [Member] | Share Exchange Agreement [Member] | ||||
Issued and outstanding equity interests | 100.00% | |||
Number of common shares in exchange for issued and outstanding equity interests | 80,000 | |||
MJP Holdings Ltd [Member] | Liao Zu Guo [Member] | January 1, 2017 [Member] | ||||
Issued and outstanding equity interests | 100.00% |
CONVERTIBLE NOTE (Details)
CONVERTIBLE NOTE (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Total convertible notes payable | $ 142,956 | $ 82,895 |
Less: Unamortized debt discount | ||
Total convertible notes | 142,956 | 82,895 |
Less: current portion of convertible notes | 142,956 | 82,895 |
Long-term convertible notes | ||
Convertible Notes Payable [Member] | November 1, 2016 [Member] | ||
Total convertible notes payable | 4,439 | 4,439 |
Convertible Notes Payable [Member] | January 1, 2017 - 1 [Member] | ||
Total convertible notes payable | 10,489 | 10,489 |
Convertible Notes Payable [Member] | January 1, 2017 - 2 [Member] | ||
Total convertible notes payable | 6,200 | 6,200 |
Convertible Notes Payable [Member] | January 1, 2017 - 3 [Member] | ||
Total convertible notes payable | 3,483 | 3,422 |
Convertible Notes Payable [Member] | June 30, 2017 [Member] | ||
Total convertible notes payable | 9,969 | 9,969 |
Convertible Notes Payable [Member] | April 1, 2018 - 1 [Member] | ||
Total convertible notes payable | 10,000 | 10,000 |
Convertible Notes Payable [Member] | April 1, 2018 - 2 [Member] | ||
Total convertible notes payable | 10,000 | 10,000 |
Convertible Notes Payable [Member] | June 30, 2018 [Member] | ||
Total convertible notes payable | 28,376 | 28,376 |
Convertible Notes Payable [Member] | July 5, 2018 - 1 [Member] | ||
Total convertible notes payable | 30,000 | |
Convertible Notes Payable [Member] | July 5, 2018 - 2 [Member] | ||
Total convertible notes payable | 15,000 | |
Convertible Notes Payable [Member] | July 5, 2018 - 3 [Member] | ||
Total convertible notes payable | $ 15,000 |
CONVERTIBLE NOTE (Details Narra
CONVERTIBLE NOTE (Details Narrative) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2018USD ($)Integer$ / shares | Jun. 30, 2017USD ($)$ / shares | Sep. 30, 2018USD ($)Integer$ / shares | Sep. 30, 2017USD ($) | Jun. 30, 2018USD ($)$ / sharesshares | |
Amount due to relates parties | $ 186,281 | $ 41,025 | $ 186,281 | ||
Convertible note beneficial conversion feature | 60,000 | ||||
Amortization of debt discount | 60,000 | 2,060 | |||
Interest expense | 12,034 | $ 3,275 | |||
Accrued interest | 23,727 | 35,808 | 23,727 | ||
Convertible note issued | $ 82,895 | $ 142,956 | $ 82,895 | ||
Convertible Notes Payable [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.01 | $ 0.01 | $ 0.01 | ||
Convertible note bearing interest | 30.00% | 35.00% | |||
Convertible note beneficial conversion feature | $ 28,376 | $ 9,969 | |||
Operating expenses | $ 28,376 | $ 9,969 | |||
Convertible Notes Payable [Member] | July 5, 2018 1, 2 and 3 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.01 | $ 0.01 | |||
Amount due to relates parties | $ 145,523 | $ 145,523 | |||
Convertible note bearing interest | 30.00% | ||||
Number of notes issued | Integer | 3 | ||||
Convertible note beneficial conversion feature | $ 60,000 | ||||
Convertible note issued | $ 60,000 | $ 60,000 | |||
Convertible Notes Payable [Member] | April 1, 2018 - 1 and 2 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.01 | ||||
Patent of purchase | $ 10,000 | ||||
Convertible note bearing interest | 45.00% | ||||
Number of notes issued | Integer | 2 | ||||
Convertible note beneficial conversion feature | $ 20,000 | ||||
Convertible note issued | $ 20,000 | ||||
Convertible Notes Payable [Member] | January 1, 2017 - 3 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.005 | ||||
Amount due to relates parties | $ 3,352 | ||||
Convertible Notes Payable [Member] | January 1, 2017 - 2 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.005 | ||||
Amount due to relates parties | $ 14,289 | ||||
Convertible note bearing interest | 45.00% | ||||
Convertible note beneficial conversion feature | $ 14,289 | ||||
Common stock converted, shares | shares | 760,000 | ||||
Common stock converted, amount | $ 3,800 | ||||
Convertible Notes Payable [Member] | January 1, 2017 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.005 | ||||
Amount due to relates parties | $ 10,000 | ||||
Convertible note bearing interest | 45.00% | ||||
Convertible note beneficial conversion feature | $ 10,000 | ||||
Common stock converted, shares | shares | 760,000 | ||||
Common stock converted, amount | $ 3,800 | ||||
Convertible Notes Payable [Member] | November 1, 2016 [Member] | |||||
Convertible note conversion price | $ / shares | $ 0.005 | ||||
Amount due to relates parties | $ 18,239 | ||||
Convertible note bearing interest | 4.00% | ||||
Maturity date | Nov. 1, 2017 | ||||
Convertible note beneficial conversion feature | $ 18,239 | ||||
Common stock converted, shares | shares | 760,000 | ||||
Common stock converted, amount | $ 3,800 | ||||
Convertible Notes Two [Member] | January 1, 2017 - 3 [Member] | |||||
Convertible note bearing interest | 45.00% | ||||
Convertible note beneficial conversion feature | $ 3,352 |
DUE TO RELATED PARTIES (Details
DUE TO RELATED PARTIES (Details Narrative) - USD ($) | 3 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2018 | |
Due to related parties | $ 41,025 | $ 186,281 | |
Convertible note issued | 142,956 | $ 82,895 | |
Debt forgiveness | 85,523 | ||
CEO [Member] | |||
Due to related parties | 41,025 | ||
On July 5, 2018 [Member] | |||
Due to related parties | 145,523 | ||
Convertible note issued | 60,000 | ||
Debt forgiveness | $ 85,523 |
CAPITAL STOCK (Details Narrativ
CAPITAL STOCK (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Jun. 30, 2018 | |
Capital Stock | ||
Common stock, shares issued | 15,579,749 | 15,579,749 |
Common stock, shares outstanding | 15,579,749 | 15,579,749 |
Proceeds from issuance of common stock | $ 0 | |
Warrants or options outstanding | 0 |